Characteristics and prognosis of rrDLBCL with TP53 mutations and a high‐risk subgroup represented by the co‐mutations of DDX3X‐TP53
Article in Cancer Medicine (March 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis
Article in Clinical and Experimental Medicine (February 2023)
Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles
Article in Frontiers in Oncology (February 2023)